Low bone turnover in patients with renal failure

Area of Science:

• Nephrology
• Endocrinology
• Bone Metabolism

Background:

• Renal failure leads to metabolic bone disease, with changing prevalence of renal osteodystrophy (ROD) types.
• Adynamic bone disease (ABD) is characterized by low osteoblast numbers and normal mineralization, with unclear pathogenesis.
• Osteomalacia, rarer in Western countries, involves defective bone mineralization, often linked to vitamin D deficiency.

Purpose of the Study:

• To investigate the changing landscape of renal osteodystrophy (ROD) in renal failure.
• To explore the pathophysiology of adynamic bone disease (ABD) and osteomalacia.
• To identify potential contributing factors to osteomalacia in uremic patients.

Main Methods:

• Review of historical and recent data on ROD prevalence.
• Analysis of metabolic abnormalities and vitamin D status in patients with osteomalacia.
• Measurement of bone strontium levels in patients with different ROD types.
• Experimental investigation using a chronic renal failure rat model.

Main Results:

• Adynamic bone disease (ABD) prevalence has increased, while osteomalacia has decreased in Western countries.
• Osteomalacia is associated with low 25-(OH) vitamin D3 levels and potentially strontium accumulation.
• Elevated bone strontium levels were observed in osteomalacia patients, linked to contaminated dialysate.

Conclusions:

• The prevalence of different renal osteodystrophy (ROD) types has shifted, with a rise in adynamic bone disease (ABD).
• Strontium accumulation from contaminated dialysate may play a role in the development of osteomalacia.
• Further research is needed to elucidate ABD pathogenesis and confirm strontium's causal role in mineralization defects.